The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer

被引：0
|
作者：
Kang, Myoung Hee
Go, Se-Il
Kim, Seok-Hyun
Song, Haa-na
Kang, Jung Hun
Lee, Gyeong-won
机构：
[1] Gyeongsang Natl Univ, Sch Med, Gyeongsang Natl Univ Hosp, Div Hematol Oncol,Dept Internal Med, Jinju, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Hematol & Med Oncol,Dept Internal Med, Chang Won, South Korea
[3] Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Hematol Oncol, Jinju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e18550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18550
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio in Patients with Lung Cancer Treated with Nivolumab
    Shibata, E.
    Yokoi, T.
    Takahashi, R.
    Mikami, K.
    Kanemura, S.
    Koda, Y.
    Negi, Y.
    Fujimoto, E.
    Akano, Y.
    Tada, A.
    Minami, T.
    Kuribayashi, K.
    Kijima, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S708 - S708
  • [32] Initial neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with inoperable locally advanced non-small-cell lung cancer
    Sun, Siyu
    Qu, Yanli
    Wen, Fengyun
    Yu, Hong
    BIOMARKERS IN MEDICINE, 2020, 14 (14) : 1341 - 1352
  • [33] The prognostic nutritional index and neutrophil-to-lymphocyte ratio as prognostic factors in advanced non-small cell lung cancer patients treated with immunotherapy
    Cipriano, E.
    Magalhaes, H.
    Estevinho, F.
    Sottomayor, C.
    ANNALS OF ONCOLOGY, 2019, 30 : 6 - 6
  • [34] Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer
    Iwasaki, Masashi
    Ishihara, Shunta
    Okada, Satoru
    Shimegi, Reona
    Shimomura, Masanori
    Inoue, Masayoshi
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 5699 - 5707
  • [35] Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer
    Masashi Iwasaki
    Shunta Ishihara
    Satoru Okada
    Reona Shimegi
    Masanori Shimomura
    Masayoshi Inoue
    Annals of Surgical Oncology, 2022, 29 : 5699 - 5707
  • [36] Neutrophil-to-Lymphocyte Ratio is an Independent Prognostic Indicator for Overall Survival among Patients with Oligometastatic Non-Small Cell Lung Cancer
    Ludmir, E. B.
    Farooqi, A.
    Mitchell, K. G.
    Antonoff, M.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E517 - E517
  • [37] Prognostic Significance of Pretreatment Total Lymphocyte Count, Neutrophil-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in Limited-Stage Small Cell Lung Cancer
    Suzuki, R.
    Shiraishi, Y.
    Wei, X.
    Allen, P. K.
    Lin, S. H.
    Komaki, R. U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S115 - S115
  • [38] Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy
    Kutlu, Yasin
    Aydin, Sabin Goktas
    Bilici, Ahmet
    Oven, Bala Basak
    Olmez, Omer Fatih
    Acikgoz, Ozgur
    Hamdard, Jamshid
    MEDICINE, 2023, 102 (15)
  • [39] Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
    Diem, Stefan
    Schmid, Sabine
    Krapf, Mirjam
    Flatz, Lukas
    Born, Diana
    Jochum, Wolfram
    Templeton, Arnoud J.
    Fruh, Martin
    LUNG CANCER, 2017, 111 : 176 - 181
  • [40] Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Solid Cancers
    Sarkar, R. R.
    Bryant, A. K.
    Guss, Z. D.
    Bruggeman, A.
    Sharabi, A.
    Rose, B. S.
    Murphy, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S121 - S122
12345